This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Pirlimycin (PIR) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for pirlimycin. It can be applied to ELISA, WB, FIA and CLIA assays of pirlimycin.
Specifications
Target Information
Pirlimycin is a macrolide antibiotic that targets the 50S subunit of bacterial ribosomes. It binds to the 23S rRNA, inhibiting protein synthesis by preventing the translocation of peptidyl-tRNA during the elongation phase. This action disrupts the formation of functional proteins, leading to bacterial cell death. Pirlimycin is effective against a wide range of Gram-positive bacteria, making it a valuable tool in veterinary medicine for treating mastitis and other infections. Its specific interaction with the ribosome makes it a relevant target for antibody development to enhance detection and monitoring in clinical and research settings, supporting effective treatment and management of bacterial infections.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
